C-erbB-2 protein expression and clinicopathologic features in colorectal cancer

Oncology Reports

Volumn 7, Issue 6, 2000, Pages 1229-1233

  Ishida, Hideki ^a   Sadahiro, Sotaro ^a   Suzuki, Toshiyuki ^a   Ishikawa, Kenji ^a   Tajima, Tomoo ^a   Makuuchi, Hiroyasu ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

c erbB 2; Colorectal cancer; Liver metastasis; Lung metastasis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; BIOSYNTHESIS; CANCER INVASION; CANCER STAGING; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; LIVER TUMOR; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2;

EID: 0034323573     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.6.1229     Document Type: Article

References (40)

1. Semba K, Kamata N, Toyoshima K and Yamamoto T: A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbR-1/ epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA 82: 6497-6501, 1985.
2. Matsuda S and Yamamoto T: Regulation of the c-erbB-2 transforming ability. Jpn J Clin Med 48: 1679-1684, 1990.
3. Uehara T, Kaneko Y, Kanda N, Yamamoto T, Higashi Y, Nomoto C, Izumo T, Takayama S and Sakurai M: c-erbB-2 and c-erbA.-1 (ear-1) gene amplification and c-erbB-2 protein expression in Japanese breast cancer: their relationship to the histology and other disease parameters. Jpn J Cancer Res 81: 620-624, 1990.
4. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987.
5. Van De Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O and Nusse R: Neu-protein overexpression in breast cancer: association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 319: 1239-1245,1988.
6. Tsuda H, Hirohashi S, Shimosato Y, Hirota E and Yamamoto H: Oncogene. Jpn J Breast Cancer 4: 293-302, 1989.
7. Osaki A, Toi M, Yamada H, Kawami H, Kuroi K and Yoge T: Prognostic significance of expression of c-erbB-2 oncoprotein in breast cancer patients. Jpn J Cancer Chemother 18: 1181-1185, 1991.
8. Kitagawa Y, Ueda M, Ando N, Ozawa S, Shimizu N and Kitajima M: Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2: 909-914, 1996.
9. Ikeda Y, Ozawa S, Ando N, Kitagawa Y, Ueda M and Kitajima M: Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. Ann Thorac Surg 62: 835-838, 1996.
10. Tsugawa K, Fushida S and Yonemura Y: Amplification of the c-erbR-2 gene in gastric carcinoma: correlation with survival. Oncology 50: 418-425, 1993.
11. Yonemura Y, Ohoyama S, Ninomiya I, Kinoshita K, Fushida S, Kimura H, Kosaka T, Yamaguchi A, Miwa K and Miyazaki I: Correlationship between c-erbB2 protein expression and clinical outcome in gastric cancer. Jpn J Gastroenterol Surg 23: 2747-2750, 1990.
12. Aoyagi K, Koufuji K, Kodama I, Ohta J, Yakamiya H, Mizutani K. Takeda J and Shirouzu K: Immunohistochemical analysis of c-erbB-2 and nm23 expression in early gastric carcinoma. Jpn J Gastroenterol 93: 613-619, 1996.
13. D'Emilia J, Bulovas K, D'Ercole K, Wolf B, Steele G Jr and Summerhayes IC: Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon. Oncogene 4: 1233-1239, 1989.
14. neu) in normal and transformed epithelial tissue of the digestive tract. Oncogene 4: 81-88, 1989.
15. Ito H, Yasui W, Ayse A, Yoshida K, Kameda T and Tahara E: ERBB2 gene expression in human gastrointestinal mucosa, adenoma and adenocarcinoma. Jpn J Cancer Dig Organs 1: 79-85, 1991.
16. Tsioulias GJ, Muto T, Morioka Y, Yamamoto T and Mori S: erbB-2 gene expression in colorectal cancer. Jpn J Exp Med 60: 343-349, 1990.
17. Kultfinger AM, Robinson BW, Quenville NF, Finley RJ and Davis NL: Correlation of epidermal growth factor receptor and c-erbB-2 oncogene product to known prognostic indicators of colorectal cancer. Surg Oncol 1: 97-105, 1992.
18. Nakae S, Urakawa T and Uematsu K: Correlationship between c-erbB-2 protein expression and clinical outcome in colorectal cancer. Jpn J Gastroenterol Surg 25: 2755-2759, 1992.
19. Ohmori K, Uchino J, Kondou Y, Sawaguchi Y, Shiroto H, Masuko H, Nakano S, Ohsawa S, Kondou M, Nishida O and Sano F: Prediction of hepatic metastasis after resection of colorectal carcinoma: from the viewpoint of pathologic features, c-erbB-2 oncoprotein expression and nuclear DNA content. Jpn J Gastroenterol Surg 24: 2963-2969, 1991.
20. Yamaguchi S, Ohki S, Jo T, Imai S, Matsuo K, Hamahata Y, Fukuno M, Tokito S, Hasegawa S, Masui H, Sato Y, Yamakoshi H, Tsuchiya S, Ohaki Y and Misugi K: Expression of c-erbB-2 protein and vessel invasion in colorectal cancer. Jpn J Cancer Chemother 19: 34-39, 1992.
21. erbB2. Science 256: 1205-1210,1992.
22. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB and Yarden Y: Isolation of the neu/HER-2 stimulatory ligand: a 44 kDa glycoprotein that induces differentiation of mammary tumor cells. Cell 69: 205-216, 1992.
23. Akiyama T, Sudo C, Ogawara H, Toyoshima K and Yamamoto T: The product of the humann c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232: 1644-1646, 1986.
24. Slamon DJ, Godolphin WJ, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF: Studies of the HRER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712, 1989.
25. Venter DJ, Tuzi NL, Kumar S and Gullick WJ: Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet 2: 69-72, 1987.
26. Wright C, Angus B, Nicholson SC, Sainsbury JR, Cairns J, Gullick WJ, Kelly P, Harris AL and Wilson Home CH: Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 49: 2087-2090, 1989.
27. Tsuda H, Hirohashi S, Shimosato Y, Tanaka Y, Hirota T, Tsugane S, Shiraishi M, Toyoshima K, Yamamoto T, Terada M and Sugimura T: Immunohistochemical study on overexpression of c-crbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients. Jpn J Cancer Res 81: 327-332, 1990.
28. Falck VG and Gullic WJ: c-erbB-2 oncogene product staining in gastric adenocarcinoma: an immunohistochemical study. J Pathol 159: 107-111,1989.
29. Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka M and Sasaki T: Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 51: 1034-1038, 1991.
30. Shimada E, Kalo M and Saito Y: Immunohistochemical study of the c-erbB-2 protein in human gastric carcinoma. J Jpn Surg Soc 94: 33-40, 1993.
31. Omori K: DNA content and c-erbB-2 oncoprotcin expression in hepatic metastases from colorectal carcinoma: in relation to clinicopathologic findings and prognosis. J Jpn Surg Soc 92: 1469-1479, 1991.
32. International Union Against Cancer: In: Manual of Clinical Oncology. 5th edition. Springer-Verlag, Berlin, pp243-252, 1990.
33. Parkes HC. Lillycrop K, Howell A and Craig RK: C-erbB-2 mRNA expression in human breast tumours: comparison with c-erbB-2 DNA amplification and correlation with prognosis. Br J Cancer 61: 39-45, 1990.
34. Clark GM II and McGuire WL: Follow-up study of HER-2/neu amplification in primary breast cancer. Cancer Res 51: 944-948, 1991.
35. Tokunaga A, Onda M, Okuda T, Teramoto T, Fujita I, Mizutani T, Kiyama T, Yoshiyuki T, Nishi K and Matsukura N: Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. Cancer 75: 1418-1425, 1995.
36. HER-2/neu correlates with the stage of disease and survival in colorectal cancer. Gastroenterology 112: 1103-1113, 1997.
37. Yusa K, Sugimoto Y, Yamori T, Yamamoto T, Toyoshima K and Tsuruo T: Low metastatic potential of clone from murine colon adenocarcinoma 26 increased by transfection of activated c-erbB-2 gene. J Natl Cancer Inst 82: 1633-1636, 1990.
38. Yu D, Hamada J, Zhang H, Nicolson GL and Hung M: Mechanisms of c-erbB-2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products. Oncogene 7: 2263-2270, 1992.
39. Berney CR, Fisher RJ, Yang J, Russell PJ and Crowe PJ: Protein markers in colorectal cancer. Ann Surg 230: 179-184, 1999.
40. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T and Toyoshima K: Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319: 230-234, 1986.